Mark W. Kroll serves as Executive at HAEMONETICS CORP, where they oversee executive responsibilities. Since joining the company, Mark W. Kroll has executed 114 insider transactions totaling $10.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 17, 2012 involved exercising options for 45,037 shares valued at $16.7K.
Mark W. Kroll currently holds 24,757 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark W. Kroll has been a net seller of HAE stock. They have purchased $98.8K and sold $9.9M worth of shares.
Mark W. Kroll's most recent insider trade was on Aug 17, 2012, when they sold 45,037 shares at $0.37 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 31, 2012 | TASR | $0 | Award | 9,300 | $N/A | Discretionary |
| May 4, 2012 | HAE | $1.4M | Sale | 20,000 | $71.09 | Discretionary |
| May 4, 2012 | HAE | $975.4K | Option Exercise | 20,000 | $48.77 | Discretionary |
| Jul 21, 2011 | HAE | $0 | Award | 944 | $N/A | Discretionary |
| Jul 29, 2010 | HAE | $0 | Award | 1,193 | $N/A | Discretionary |
| Mar 17, 2010 | TASR | $102.0K | Option Exercise | 15,000 | $6.80 | Discretionary |
| Mar 17, 2010 | TASR | $5.5K | Option Exercise | 15,000 | $0.37 | Discretionary |
| Jul 30, 2009 | HAE | $0 | Award | 367 | $N/A | Discretionary |
| Jul 31, 2008 | HAE | $0 | Award | 354 | $N/A | Discretionary |
| Oct 26, 2007 | TASR | $9.3K | Option Exercise | 25,000 | $0.37 | Discretionary |
| Oct 26, 2007 | TASR | $413.5K | Option Exercise | 25,000 | $16.54 | Discretionary |
| Aug 1, 2007 | HAE | $0 | Award | 287 | $N/A | Discretionary |